What deep vein thrombosis (DVT) prophylaxis should be used in an older bedridden patient in a long-term care facility? What do you think about heparin or compression stockings in such settings?
Is there still a place for unfractionated heparin and low-molecular-weight heparin (LMWH) in the current management of venous thromboembolism (VTE)? When to use them?
What is the best approach to antiplatelet treatment in patients on long-term anticoagulation?
What antithrombotic prophylaxis should be used in acutely ill hospitalized medical patients? Should it be used in such patients who remain at home or in long-term care institutions?
The diagnosis of venous thromboembolism (VTE) is based on assessment of the population pretest probability (PTP) of VTE. How to assess this probability?
What scoring systems are used in patients with pulmonary embolism?
What should be the duration of anticoagulation treatment in a patient after an episode of venous thromboembolism (VTE) with confirmed hypercoagulability? Which patients need lifelong treatment? In whom can we consider discontinuation?
Can antithrombotic treatment be used in a patient with liver failure? If yes, when is it recommended?
Which antithrombotic drugs should be avoided and which are preferred in elderly patients?
Should patients receiving anticoagulation treatment carry a special identification card?
English
Polski
Español
українська